In a research note issued today, UBS analyst Brent Thill reiterated a Buy rating and boosted his price target on Adobe Systems Inc. (ADBE) to $85.
UBS analyst David E. Strauss reiterates a ‘Buy’ rating on Esterline Technologies Corp.
UBS analyst A.J.
Ariad Pharmaceuticals (ARIA) had its price target reduced by UBS from $7.50 to $7.
